189 related articles for article (PubMed ID: 11549067)
21. Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs.
Lv G; Zhao L; Zhang A; Du W; Chen Y; Yu C; Pan X; Zhang Y; Song T; Xu J; Chen Y; Li L
Biotechnol Bioeng; 2011 Sep; 108(9):2229-36. PubMed ID: 21455934
[TBL] [Abstract][Full Text] [Related]
22. A reversible model of acute hepatic failure by temporary hepatic ischemia in the pig.
Benoist S; Sarkis R; Baudrimont M; Delelo R; Robert A; Vaubourdolle M; Balladur P; Calmus Y; Capeau J; Nordlinger B
J Surg Res; 2000 Feb; 88(2):63-9. PubMed ID: 10644469
[TBL] [Abstract][Full Text] [Related]
23. Effect of bioartificial liver in pigs with total ischemic liver failure.
Kamohara Y; Tsutsumi R; Kawazoe Y; Miyamoto S; Moriuchi H; Tamura T; Eguchi S; Kawashita Y; Azuma T; Fujioka H; Furui J; Kanematsu T
Transplant Proc; 2000 Nov; 32(7):2343-4. PubMed ID: 11120193
[No Abstract] [Full Text] [Related]
24. [Observation on hybrid bioartificial liver support systems in treating chronic severe hepatitis: a study of 60 cases].
Luo HT; Liu QM; Tan JJ; Ye YN; Zhang PH; Luo ZD; Long H
Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):205-9. PubMed ID: 16556417
[TBL] [Abstract][Full Text] [Related]
25. Hybrid bioartificial liver: establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use.
Kobayashi N; Okitsu T; Nakaji S; Tanaka N
J Artif Organs; 2003; 6(4):236-44. PubMed ID: 14691665
[TBL] [Abstract][Full Text] [Related]
26. Hepatocyte function during experimental use of a bioartificial liver.
Papadimitriou D; Arkadopoulos N; Kouskouni E; Tsarouxa N; Demesticha T; Kousi T; Drakopoulou M; Mitrou S; Vassileiou J; Katsorhis T; Patargias T
Transplant Proc; 2004; 36(6):1741-3. PubMed ID: 15350467
[TBL] [Abstract][Full Text] [Related]
27. Progress in bioreactors of bioartificial livers.
Yu CB; Pan XP; Li LJ
Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):134-40. PubMed ID: 19357025
[TBL] [Abstract][Full Text] [Related]
28. Reduced encephalopathy in pigs with ischemia-induced acute hepatic failure treated with a bioartificial liver containing alginate-entrapped hepatocytes.
Desille M; Mahler S; Seguin P; Mallédant Y; Frémond B; Sébille V; Bouix A; Desjardins JF; Joly A; Desbois J; Lebreton Y; Campion JP; Clément B
Crit Care Med; 2002 Mar; 30(3):658-63. PubMed ID: 11990930
[TBL] [Abstract][Full Text] [Related]
29. Functional and morphological comparison of three primary liver cell types cultured in the AMC bioartificial liver.
Poyck PP; Hoekstra R; van Wijk AC; Attanasio C; Calise F; Chamuleau RA; van Gulik TM
Liver Transpl; 2007 Apr; 13(4):589-98. PubMed ID: 17394165
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of Nafamostat Mesilate for improving the performance of a bioartificial liver using porcine hepatocytes.
Fujioka H; Eguchi S; Sugiyama N; Kawazoe Y; Kawashita Y; Kamohara Y; Azuma T; Furui J; Kanematsu T
Int J Artif Organs; 1999 Jul; 22(7):505-10. PubMed ID: 10493559
[TBL] [Abstract][Full Text] [Related]
31. Extracorporeal bioartificial liver using the radial-flow bioreactor in treatment of fatal experimental hepatic encephalopathy.
Kanai H; Marushima H; Kimura N; Iwaki T; Saito M; Maehashi H; Shimizu K; Muto M; Masaki T; Ohkawa K; Yokoyama K; Nakayama M; Harada T; Hano H; Hataba Y; Fukuda T; Nakamura M; Totsuka N; Ishikawa S; Unemura Y; Ishii Y; Yanaga K; Matsuura T
Artif Organs; 2007 Feb; 31(2):148-51. PubMed ID: 17298404
[TBL] [Abstract][Full Text] [Related]
32. Direct molecular and spectroscopic evidence for increased ammonia removal capacity of skeletal muscle in acute liver failure.
Chatauret N; Desjardins P; Zwingmann C; Rose C; Rao KV; Butterworth RF
J Hepatol; 2006 Jun; 44(6):1083-8. PubMed ID: 16530878
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a hollow fiber bioartificial liver device.
Abu-Absi SF; Seth G; Narayanan RA; Groehler K; Lai P; Anderson ML; Sielaff T; Hu WS
Artif Organs; 2005 May; 29(5):419-22. PubMed ID: 15854219
[TBL] [Abstract][Full Text] [Related]
34. Stable overexpression of arginase I and ornithine transcarbamylase in HepG2 cells improves its ammonia detoxification.
Tang N; Wang Y; Wang X; Zhou L; Zhang F; Li X; Chen Y
J Cell Biochem; 2012 Feb; 113(2):518-27. PubMed ID: 21938740
[TBL] [Abstract][Full Text] [Related]
35. Development and characterization of a hybrid bioartificial liver using primary hepatocytes entrapped in a basement membrane matrix.
Nagaki M; Miki K; Kim YI; Ishiyama H; Hirahara I; Takahashi H; Sugiyama A; Muto Y; Moriwaki H
Dig Dis Sci; 2001 May; 46(5):1046-56. PubMed ID: 11341648
[TBL] [Abstract][Full Text] [Related]
36. A bioartificial liver--state of the art.
Strain AJ; Neuberger JM
Science; 2002 Feb; 295(5557):1005-9. PubMed ID: 11834813
[TBL] [Abstract][Full Text] [Related]
37. [Design of a hollow-fiber bioreactor and perfusion study in vitro].
Shu G; Song J; Du Z; Li T; Zhang J; Cui R; Fu L; Lü W; Bi H
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):166-9. PubMed ID: 16532833
[TBL] [Abstract][Full Text] [Related]
38. Rapid, large-scale formation of porcine hepatocyte spheroids in a novel spheroid reservoir bioartificial liver.
Nyberg SL; Hardin J; Amiot B; Argikar UA; Remmel RP; Rinaldo P
Liver Transpl; 2005 Aug; 11(8):901-10. PubMed ID: 16035089
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the AMC-bioartificial liver in the anhepatic pig.
Sosef MN; Abrahamse LS; van de Kerkhove MP; Hartman R; Chamuleau RA; van Gulik TM
Transplantation; 2002 Jan; 73(2):204-9. PubMed ID: 11821731
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of a bioreactor filled with porcine hepatocytes immobilized on nonwoven fabric for ex vivo direct hemoperfusion treatment of liver failure in pigs.
Naruse K; Nagashima I; Sakai Y; Harihara Y; Jiang GX; Suzuki M; Muto T; Makuuchi M
Artif Organs; 1998 Dec; 22(12):1031-7. PubMed ID: 9876095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
